Nippon Shinyaku Co (TSE:4516) EBIT: 円36,628 Mil (TTM As of Mar. 2026)


TSE:4516 Nippon Shinyaku Co Ltd TSE:4516
90 GF Score
Price 円4,037.00
GF Value 円4,785.64
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Nippon Shinyaku Co EBIT?

Nippon Shinyaku Co TSE:4516 -0.25% 90 EBIT is 円36,628 Mil as of Mar. 2026. GuruFocus rates TSE:4516 with a GF Score™ of 90/100 and a GF Value™ of 円4,785.64 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Nippon Shinyaku Co's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was 円3,281 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was 円36,628 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Nippon Shinyaku Co's annualized ROC % for the quarter that ended in Mar. 2026 was 5.30%. Nippon Shinyaku Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 12.12%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Nippon Shinyaku Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 18.69%.


Nippon Shinyaku Co  (TSE:4516) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Nippon Shinyaku Co's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=12656 * ( 1 - 0% )/( (243029 + 234242)/ 2 )
=12656/238635.5
=5.30 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Nippon Shinyaku Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=13124/( ( (37196 + max(78956, 0)) + (37542 + max(62888, 0)) )/ 2 )
=13124/( ( 116152 + 100430 )/ 2 )
=13124/108291
=12.12 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(53661 + 48614 + 6179) - (22010 + 0 + 7488)
=78956

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(46157 + 51595 + 6328) - (33111 + 0 + 8081)
=62888

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Nippon Shinyaku Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=36628/195977.550
=18.69 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nippon Shinyaku Co EBIT Related Terms


Nippon Shinyaku Co EBIT Historical Data

* Premium members only.

The historical data trend for Nippon Shinyaku Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nippon Shinyaku Co EBIT Chart

Nippon Shinyaku Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33,420.00 30,625.00 33,945.00 36,280.00 36,628.00

Nippon Shinyaku Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,753.00 10,550.00 9,580.00 13,217.00 3,281.00

TSE:4516 vs ZTS: EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Nippon Shinyaku Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nippon Shinyaku Co EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nippon Shinyaku Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Nippon Shinyaku Co's EV-to-EBIT falls into.


TSE:4516
90GF Score
Nippon Shinyaku Co Ltd TSE:4516
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nippon Shinyaku Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円36,628 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of 円36,628 Mil mean?
Nippon Shinyaku Co (TSE:4516) has a EBIT of 円36,628 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Nippon Shinyaku Co.
Is Nippon Shinyaku Co's EBIT too high?
Nippon Shinyaku Co's current EBIT is 円36,628 Mil. Overall, Nippon Shinyaku Co has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nippon Shinyaku Co's EBIT compare to ZTS?
Nippon Shinyaku Co's EBIT of 円36,628 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Drug Manufacturers company?
A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Nippon Shinyaku Co. Nippon Shinyaku Co's current EBIT is 円36,628 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nippon Shinyaku Co stock overvalued right now?
Based on GuruFocus' analysis, Nippon Shinyaku Co (TSE:4516) is currently considered Modestly Undervalued. The stock's GF Value™ is 円4,785.64, compared to a current price of 円4,037.00 — trading 15.6% below its estimated fair value. The current EBIT is 円36,628 Mil. Nippon Shinyaku Co's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Nippon Shinyaku Co (TSE:4516), the current EBIT is 円36,628 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nippon Shinyaku Co (TSE:4516) Overvalued in 2026?

Based on GuruFocus' analysis, Nippon Shinyaku Co stock appears to be undervalued. The current stock price of 円4,037.00 is trading 15.6% below its estimated GF Value™ of 円4,785.64. GuruFocus considers Nippon Shinyaku Co to be Modestly Undervalued.

Key valuation signals for TSE:4516:

  • EBIT: 円36,628 Mil
  • GF Value™: 円4,785.64 vs. price of 円4,037.00 (15.6% below fair value)
  • GF Score™: 90/100 with 3 warning signs

No single metric tells the full story. See the TSE:4516 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nippon Shinyaku Co Business Description

Other Exchanges NPPNY:USA
Address 14, Kisshoin Nishinosho Monguchicho, Minami-ku, Kyoto, JPN, 601-8550
Nippon Shinyaku Co Ltd is engaged in the pharmaceuticals and functional food businesses. The Pharmaceuticals Business develops and sells treatments for urological disorders, blood cancer, rare and intractable diseases, and gynecological conditions. The Functional Food Business produces and sells health food ingredients, quality-stabilizing preservatives, protein preparations, and supplements. It generates the majority of its revenue from the Pharmaceuticals segment.
90GF Score

Get the complete analysis for TSE:4516

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円4,037.00
Price
円4,785.64
GF Value